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PHENYLKETONURIA (PKU) which, in Northern Ireland, has anincidence ofone
in 4362 newborns,' is a metabolic disorder in which the conversion ofphenylalanine
to tyrosine is impaired due to the reduction in activity of the enzyme phenylalanine
hydroxylase. Itis inherited an anautosomal recessivetrait. Ifbeguninearlyinfancy,
a low phenylalanine diet which controls the biochemical abnormalities prevents
severe mental retardation. However, since j9572 it has been recognised that infants
born to women with PKU have a high risk of mental retardation, microcephaly,
congenital heart disease, and low birth weight. We report a family in which two
sisters, both with unrecognised PKU had a total of six children, all of whom had
microphaly with mental retardation.
CASE HISTORY
The index patient (Figure II1,13), a two-month-old infant was referred to the
Department of Medical Genetics for investigation of microcephaly. His dizygotic
male co-twin (Figure III,14) was similarly affected. Investigation of the family
revealed that an older sister and two older brothers (Figure III, 10-12) were also
mentally retarded with microcephaly. Extensive cytogenetic, radiographic, and
virological studies of these children gave negative results.
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1 2---3The mother (Figure 11,9), born in 1947, was found to have a plasma phenylalanine
value of 1520 umol/l, as in classical PKU. She commenced school at 6 years old and
left at 15 years ofage without ever passing any examinations. She married at the age
of 19 years. For a few years after leaving school, she worked as a clipper in a shirt
factory. She is the youngest in a sibship ofnine. Ofthree older brothers, two (Figure
II,2 & 3) were severely mentally retarded with plasma phenylalanine values of 1698
and 1800 umol/l, and had unrecognised classical PKU. Of her five sisters, one
(Figure 11,7) also had unrecognised classical PKU with severe mental retardation
and a plasma phenylalanine value of 1557 umol/l. Another sister (Figure II,8) was
an unrecognised PKU with a phenylalanine level of 1479 umol/l. This sister had one
child (Figure 111,9), a male, who was severely mentally retarded with microcephaly.
DISCUSSION
This family illustrates the tragic fact that women with PKU have an extremely
high risk of having children with mental retardation, microcephaly, and congenital
abnormalities. Since the first recognition of the maternal PKU problem,2 many
reviews on this subject have been published.3'4 3,6,7,8 In all, a total of 524
pregnancies in 155 mothers with PKU or some degree of hyperphenylalaninaemia
have been documented. The non-PKU offspring of women with PKU have mental
retardation, microcephaly, congenital heart disease, and low birth weight. Women
with PKU also have an increased frequency of spontaneous abortion.
The mechanisms by which the mental retardation and the congenital
abnormalities result from maternal PKU is uncertain. Abnormalities of cerebral
lipids in a non-PKU offspring of a PKU woman were similar to those observed in
patients with PKU, suggesting that the fetal brain damage was related to prenatal
exposure to high levels of phenylalanine and/or phenylalanine metabolites in the
mother. Alternatively, in the rat, a reduced fetal tissue concentration of
L-tryptophane, impaired uptake ofL-tyrosine and L-tryptophane and reduced brain
pyruvate kinase activity has been found in fetuses of hyperphenylalaninaemic
dams.'0 The prenatal brain damage thus could be due to decreased protein synthesis
due to the unavailability of tryptophane.
Treatment with a low-phenylalanine diet has been given during 30 pregnancies."
It appears that treatment begun in the first trimester results in better intellectual
development in the offspring than when treatment is begun later in pregnancy.
However, there was no clearly beneficial effect in preventing microcephaly or
congenital heart disease. Even good biochemical control, as reflected by periodic
maternal blood phenylalanine levels, is no guarantee of a normal outcome. One
woman, despite the introduction of a low phenylalanine diet five weeks after
conception 12 gave birth to an infant with microcephaly and severe cardiac
abnormalities. Beginning treatment prior to conception might be a reasonable
approach. The offspring from two pregnancies in which treatment was started prior
to conception resulted in normal offspring.'3 14 However, with such a small number
of cases treated preconceptionally no firm conclusion can be made as to the
effectiveness of such treatment. *The identification of women with PKU is
important. The M.R.C. and D.H.S.S. now have a national register of fertile women
with PKU. All known PKU females enter this register at the age of 14 years. Women
with PKU who want children should plan their pregnancies to allow initiation of
treatment before conception.
134SUMMARY
A family is described in which two women with unrecognised phenylketonuria
had a total of six pregnancies of which one was a spontaneous abortion and five
resulted in six children with severe mental retardation and microcephaly. The
possibility of dietary management during pregnancy in preventing severe mental
retardation in their offspring is reviewed.
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